# CBD Research Overview: Current State of the Science

By Robin Roy Krigslund-Hansen | 12+ years in CBD industry
Last updated: January 21, 2026

---

## Quick Summary

CBD research has expanded dramatically, with thousands of studies examining its effects. Strong evidence supports CBD for certain epilepsies (FDA/EMA approved), moderate evidence exists for anxiety and pain, and preliminary research explores many other applications. Understanding research levels helps set realistic expectations.

---

## Key Takeaways

- Strongest evidence: Epilepsy (FDA-approved Epidiolex)
- Moderate evidence: Anxiety, pain, sleep
- Preliminary: Many other conditions
- Research quality varies significantly
- Human trials lag behind animal studies

---

## Evidence Levels by Condition

### Strong Evidence

**Epilepsy:**
- Epidiolex approved by FDA (2018) and EMA
- Multiple randomised controlled trials
- Reduces seizures in Dravet, Lennox-Gastaut, Tuberous Sclerosis
- This is the gold standard for CBD research

### Moderate Evidence

**Anxiety:**
- Multiple human trials (mostly small)
- Consistent positive results
- Various anxiety types studied
- Mechanism well-understood (5-HT1A)

**Pain/Inflammation:**
- Strong preclinical evidence
- Limited human trials
- Combination products (CBD+THC) better studied
- More research needed

### Preliminary Evidence

**Many conditions under investigation:**
- Depression
- Sleep disorders
- PTSD
- Addiction
- Neuroprotection
- Skin conditions

---

## Research Challenges

### Why Evidence Is Limited

- Cannabis scheduling hindered research
- Funding limitations
- Product standardisation issues
- Regulatory complexity
- Long study timelines

### Quality Concerns

- Many studies are small
- Short duration common
- Inconsistent products used
- Publication bias exists

---

## Reading Research Critically

### What to Look For

- Study type (RCT is gold standard)
- Sample size
- Duration
- Dosing protocol
- Funding source

### Hierarchy of Evidence

From strongest to weakest:
1. Meta-analyses of RCTs
2. Randomised controlled trials
3. Observational studies
4. Animal studies
5. In vitro (cell) studies
6. Case reports/anecdotes

---

## My Take

CBD research is real but nuanced. The epilepsy evidence is pharmaceutical-grade solid. Anxiety evidence is promising and consistent. Beyond that, we're often working with preliminary data. This doesn't mean CBD doesn't work for other conditionsâ€”absence of proof isn't proof of absence. But it means expectations should be calibrated to evidence levels.

---

## Related Articles

- [CBD Clinical Trials](/knowledge/cbd-clinical-trials)
- [Key CBD Anxiety Studies](/knowledge/key-cbd-anxiety-studies)
- [Epidiolex Study](/knowledge/epidiolex-study)

---

*This article is for educational purposes only.*
